跳至主要内容
临床试验/CTRI/2025/08/092363
CTRI/2025/08/092363尚未招募不适用

An Interventional Study to Assess the Role of Individualized Homoeopathic Medicine in the Cases of Chronic Urticaria Using CU-Q2OL Questionnaire

swasthya kalyan Homoeopathic Medical College And Research Centre1 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2025年8月29日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
57
试验地点
1
主要终点
At the end of the study, it is expected that individualized Homoeopathic medicine will play an effective role in the treatment of chronic urticaria, as measured by the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).

研究概览

简要总结

This study is a interventional and single arm to see the role of individualized homoeopathic medicine in the cases of chronic urticaria . the study will be conducted at Swasthya Kalyan Homoeopathic Medical College and Research Centre, Jaipur . the primary outcome measure assess through CU-Q2OL QUESTINNAIRE ( chronic urticaria quality of life questionnaire) , regular follow-up assessment . it will be conducted for 1 year. the objectives are to assess the changes after homoeopathic intervention to the cases of chronic urticaria . and see the what commonly prescribed homoeopathic medicine for the treatment of chronic urticaria over the study period.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed cases of chronic urticaria, based on EAACI/GA²LEN/EDF/WAO consensus guidelines or ICD-11 clinical guidance —including both chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU)—presenting with recurrent wheals angioedema or both persisting for six weeks or more.
  • Patients aged 18 and above.
  • Both the sexes.
  • Patients willing to participate and provide written informed consent.

排除标准

  • Patients unable or unwilling to provide written informed consent.
  • Patients with other medical conditions or those receiving systemic corticosteroids immunosuppressive therapy or alternative treatments that could affect the outcome of the study will be excluded.
  • Patients with other dermatological or systemic conditions that can mimic chronic urticaria—such as urticarial vasculitis bullous pemphigoid mastocytosis (e.g. urticaria pigmentosa) cutaneous lupus erythematosus papular urticaria drug-induced dermatoses or napkin-area infection Schnitzler’s Syndrome Gleich’s Syndrome or Well’s Syndrome (e.g. Eosinophilic Cellulitis).
  • Patients with systemic autoinflammatory disorders such as Cryopyrin-Associated Periodic Syndromes (CAPS) including Familial Cold Autoinflammatory Syndrome (FCAS) Muckle-Wells Syndrome (MWS) and Neonatal-Onset Multisystem Inflammatory Disease (NOMID).

结局指标

主要结局

At the end of the study, it is expected that individualized Homoeopathic medicine will play an effective role in the treatment of chronic urticaria, as measured by the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).

时间窗: At Baseline and after 3 months

• It is expected that analysis of the study data will identify the most commonly prescribed Homoeopathic medicine in cases of chronic urticaria.

时间窗: At Baseline and after 3 months

次要结局

未报告次要终点

研究者

发起方
swasthya kalyan Homoeopathic Medical College And Research Centre
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Pushpanjali Daswani

swasthya kalyan homeopathic medical college jaipur

研究点 (1)

Loading locations...

相似试验